argenx SE (ARGX)
378.30
-8.70
(-2.25%)
USD |
NASDAQ |
Jun 17, 16:00
377.70
-0.60
(-0.16%)
Pre-Market: 20:00
argenx Cash and Short Term Investments (Quarterly)
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.180B |
June 30, 2023 | 1.997B |
December 31, 2022 | 2.193B |
June 30, 2022 | 2.597B |
December 31, 2021 | 2.337B |
June 30, 2021 | 2.731B |
December 31, 2020 | 1.996B |
June 30, 2020 | 2.174B |
December 31, 2019 | 1.501B |
June 30, 2019 | 1.074B |
June 30, 2019 | 1.074B |
December 31, 2018 | 645.81M |
Date | Value |
---|---|
June 30, 2018 | 391.78M |
June 30, 2018 | 391.78M |
December 31, 2017 | 431.62M |
June 30, 2017 | 198.39M |
December 31, 2016 | 101.73M |
June 30, 2016 | 120.96M |
December 31, 2015 | 46.28M |
June 30, 2015 | 56.69M |
December 31, 2014 | 68.06M |
June 30, 2014 | 28.84M |
March 31, 2014 | 28.76M |
December 31, 2013 | 32.06M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.074B
Minimum
Jun 2019
3.180B
Maximum
Dec 2023
2.078B
Average
2.174B
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | 7.606M |
Koninklijke Philips NV | -- |
Qiagen NV | 893.13M |
Trinity Biotech PLC | 5.776M |
Mereo BioPharma Group PLC | 48.66M |